Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) Consolidated Net Income: 2009-2025

Historic Consolidated Net Income for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $38.2 million.

  • BIO-TECHNE's Consolidated Net Income rose 13.65% to $38.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.8 million, marking a year-over-year decrease of 75.73%. This contributed to the annual value of $22.2 million for FY2025, which is 82.61% down from last year.
  • BIO-TECHNE's Consolidated Net Income amounted to $38.2 million in Q3 2025, which was up 155.48% from -$68.8 million recorded in Q2 2025.
  • Over the past 5 years, BIO-TECHNE's Consolidated Net Income peaked at $89.7 million during Q3 2022, and registered a low of -$68.8 million during Q2 2025.
  • For the 3-year period, BIO-TECHNE's Consolidated Net Income averaged around $27.7 million, with its median value being $34.9 million (2024).
  • Per our database at Business Quant, BIO-TECHNE's Consolidated Net Income skyrocketed by 563.12% in 2022 and then plummeted by 16,219.44% in 2025.
  • BIO-TECHNE's Consolidated Net Income (Quarterly) stood at $72.1 million in 2021, then tumbled by 30.61% to $50.0 million in 2022, then slumped by 45.08% to $27.5 million in 2023, then increased by 27.03% to $34.9 million in 2024, then grew by 13.65% to $38.2 million in 2025.
  • Its Consolidated Net Income stands at $38.2 million for Q3 2025, versus -$68.8 million for Q2 2025 and $22.6 million for Q1 2025.